Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Credefi Finance Partners with Nilos and Sets New Industry Standards with Innovative Financial Solutions
-
Schouw & Co. share buy-back programme, week 9 2024
-
Omega Park inaugurates the Makwa Foundation for the Conservation and Protection of Endangered Species
-
Nashville's Gulch Lands Major Tenant as Calvetti Ferguson Signs Office Lease
-
Nashville's Gulch Lands Major Tenant as Calvetti Ferguson Signs Office Lease
-
Dave Reports Record Fourth Quarter and Full Year 2023 Results; Reaches Significant Quarterly Profitability Milestone
-
Adex Mining Announces New Loan Agreement With Great Harvest
-
Cartier cuts 7.7 g/t Au over 2.0 m in the VG Structure of the Chimo Mine Project
-
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
-
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market
-
Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024
-
Whitestone REIT Increases Annual Cash Dividend by 3%
-
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
-
Study: Most CMOs Fail to Understand AI Beyond ChatGPT
-
SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
-
General Motors, Magna, and Wipro Team Up to Develop Automotive Software Marketplace: ‘SDVerse’
-
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
-
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Form 8.3 - [SMART METERING SYSTEMS PLC] - 04 03 2024 - (CGWL)
-
Changes in the management of Oma Savings Bank Plc
-
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when add
-
Form 8.3 - [LXi REIT PLC] - 04 03 2024 - (CGWL)
-
Form 8.3 - [LONDONMETRIC PROPERTY PLC] - 04 03 2024 - (CGWL)
-
DIFI Chairman Stuart Daughtridge Nominated for Satellite Executive of the Year
-
Ladybug Announces Acquisition of E-Commerce Generating $2.4 Million Annual Revenue
-
Tecan schedules conference call on March 12 to discuss Full-Year 2023 Financial Results
-
Man Group PLC : Form 8.3 - Barratt Developments Plc
-
PSC Consulting bolsters leadership team with appointment of European head
-
Trawick International Expands Global Accident & Health Division with Three Key UK Hires
-
Trawick International Expands Global Accident & Health Division with Three Key UK Hires
-
Cartesian Therapeutics Announces New Employment Inducement Grant
-
Safran Selects Gilat for Strategic, Multimillion-Dollar In-Flight Connectivity Program
-
Arqit announces reseller agreement with Total Computers
-
How news producers can drive consumers toward misinformation - even when they want the truth
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nasdaq Outlines Strategy to Deliver Next Phase of Resilient and Scalable Growth
-
First Watch Restaurant Group, Inc. Reports Strong 2023 Financial Results and Provides 2024 Outlook
-
Broadwind Announces Fourth Quarter and Full-Year 2023 Results
-
Hemlo Explorers Provides Update on Pic Project Option for 2023
-
Aya Gold & Silver Announces At-Depth High-Grade Results Including New Mineralized Zone Within Rhyolite at Zgounder
-
Fraser Institute News Release: Alberta high schools can improve student performance despite challenges
-
Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland
-
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Manufacturer CMOs Reevaluate Retail Media Network Investments
-
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
-
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
-
Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
-
Interactive Strength Inc. (Nasdaq: TRNR) Receives Letter From Nasdaq Confirming That the Company Complies With the Stockholders’ Equity Requirement
